{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:54:04Z","timestamp":1786978444106,"version":"build-2736575974"},"reference-count":3,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":168,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:p>A 55-year-old woman with a moderately differentiated cutaneous squamous cell carcinoma (cSCC) of the upper lip experienced initial tumour growth and new lymphadenopathy after starting immunotherapy with Cemiplimab, but achieved complete remission with no adverse events after five infusions. This case underscores the potential of immunotherapy for cSCC in sensitive head and neck areas and illustrates the phenomenon of pseudoprogression, where apparent tumour growth can occur before clinical improvement.<\/jats:p>","DOI":"10.1002\/ski2.400","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T17:14:50Z","timestamp":1717089290000},"source":"Crossref","is-referenced-by-count":1,"title":["Pseudoprogression of Cutaneous Squamous Cell Carcinoma Invading the Super Vermillion Border Following Programmed Death-1 Inhibitor Monotherapy"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8637-8458","authenticated-orcid":false,"given":"Sach","family":"Thakker","sequence":"first","affiliation":[{"name":"Georgetown University School of Medicine , Washington, District of Columbia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naghmeh","family":"Yousefzadeh","sequence":"additional","affiliation":[{"name":"Sonic Healthcare Dermatopathology , Sterling, Virginia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Al-Mondhiry","sequence":"additional","affiliation":[{"name":"Inova Schar Cancer Institute , Fairfax, Virginia ,","place":["USA"]},{"name":"University of Virginia School of Medicine , Charlottesville, Virginia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"issue":"4","key":"2025112605423500000_ski2400-bib-0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2021.100045","article-title":"Evidence-based consensus recommendations for the evolving treatment of patients with high-risk and advanced cutaneous squamous cell carcinoma","volume":"1","author":"Rabinowits","year":"2021","journal-title":"JID Innov"},{"issue":"4","key":"2025112605423500000_ski2400-bib-0002","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N Engl J Med"},{"issue":"18","key":"2025112605423500000_ski2400-bib-0003","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1002\/cncr.32190","article-title":"Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: a subgroup analysis of a randomized phase 3 clinical trial","volume":"125","author":"Haddad","year":"2019","journal-title":"Cancer"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/4\/ski2.400\/60660676\/skinhd_4_4_e400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/4\/ski2.400\/60660676\/skinhd_4_4_e400.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:42:41Z","timestamp":1764153761000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.400\/7896782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":3,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5,30]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.400","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,5,30]]},"article-number":"ski2.400"}}